New anticoagulants: beyond heparin, low‐molecular‐weight heparin and warfarin
Comparison
New anticoagulant agents in advanced stages of… vs Traditional anticoagulants
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Informs research on novel anticoagulants; does not yet warrant changes in thromboembolism management.
Structured PICO
I
Intervention
New anticoagulant agents in advanced stages of clinical testing
C
Comparator
Traditional anticoagulants (heparin, low-molecular-weight heparin, warfarin)
This review summarizes the development of new anticoagulant drugs for the prevention and treatment of venous and arterial thromboembolism, addressing the limitations of traditional therapies.
Cite This Study
Bates et al. (2005) studied this question.